Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Dr. Allison Betof Warner from Stanford University joins Rahul Gosain, MD and Rohit Gosain, MD, on the Oncology Brothers podcast to discuss melanoma treatment. The conversation covers the…
Christopher Hourigan, MD, PhD, associate professor at Johns Hopkins and principal investigator at the National Heart, Lung, and Blood Institute of the National Institutes of Health, highlights his…
In this double interview, Ross Camidge, MD, PhD, of the University of Colorado Cancer Center, and Lyudmila A. Bazhenova, MD, of UC San Diego Health, provide insights into…
New techniques and technology advancements in the field of radiation oncology are the topics of discussion in this interview with Amin J. Mirhadi, MD, associate professor of radiation…
In this video, Benjamin P. Levy, MD, assistant professor of oncology and clinical director of Medical Oncology for the Sidney Kimmel Cancer Center at Johns Hopkins Medicine, stresses…
Geoffrey Oxnard, MD, associate professor of medicine at Harvard Medical School, discusses the advancements in treatments for lung cancer over the past 10 to 15 years. Even though…
In an interview at the 18th British Thoracic Oncology Group (BTOG) 2020 congress, Sanjay Popat, BSc, MBBS, FRCP, PhD, of The Royal Marsden NHS Foundation Trust in London,…
Heather A. Wakelee, MD, thoracic oncologist and professor of medicine at Stanford University Medical Center, discusses the decisions that go into planning treatments for newly diagnosed, advanced stage…
Lyudmila A. Bazhenova, MD, professor of medicine at UC San Diego Health, discusses the lack of data on chemoimmunotherapy or monotherapy immunotherapy for treatment of ALK-fused non-small cell…
Ashish Saxena, MD, PhD, assistant attending at New York-Presbyterian Hospital and assistant professor of medicine at Weill Cornell Medical College, reviews first-line therapies in non-small cell lung cancer.…
Results from a cohort study suggest that vision loss, a common side effect after plaque radiotherapy for uveal melanoma, may be mitigated or avoided entirely thanks to prophylactic…
